pocketful logo
Rekvina Labs Ltd logo

Rekvina Labs Ltd

NSE: BSE: 526075

₹32.85

(1.99%)

Tue, 24 Mar 2026, 02:17 am

mtf coin illustrationMTF 5x

Rekvina Labs Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

  • Market Cap

    20.19

  • Net Profit

    -0.14

  • P/B

    0

  • Sector P/E

    39.77

  • P/E

    0

  • EV/EBITDA

    0

  • Debt/Equity (Industry)

    1.23

  • Interest Cover (Industry)

    2.84

  • ROCE (Industry)

    14.19

  • RONW (Industry)

    15.11

  • ROE

    0

  • ROCE

    0

  • Debt/Equity

    0

  • EPS (TTM)

    0

  • Dividend Yield

    0

  • Book Value

    -1.25

  • Interest Cover

    0

Analysis

No Result Found

Read More

Financials

No Result Found

Read More

Ratios

No Result Found

Read More

Shareholding

ShareholdersDEC 2025SEPT 2025JUN 2025MAR 2025DEC 2024
Promoters41.3041.3041.3041.3041.30
FII00000
DII00000
Public58.7058.7058.7058.7058.70
Government00000

Read More

Technical Analysis

RSI

92.32

MACD

3.33

50 DMA

20.57

200 DMA

8.91

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic48.1235.5331.3422.9418.7510.35-
Fibonacci35.5330.7227.7522.9418.1315.1610.35
Camarilla30.6029.4528.2922.9425.9924.8323.68

Pivots Level: Classic

R3

+25.18

48.12

R2

+12.59

35.53

R1

+8.39

31.34

22.94
22.94
Pivot Point
LTP: 33.50

S1

-4.20

18.75

S2

-12.59

10.35

S3

-22.94

-

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    31.13

  • 20-EMA

    28.82

  • 30-EMA

    26.40

  • 50-EMA

    22.28

  • 100-EMA

    16.28

  • 200-EMA

    11.79

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
16 Mar 2026egm
06 Feb 2026board-meetingsQuarterly Results
14 Nov 2025board-meetingsQuarterly Results, Half Yearly Results
01 Sept 2025agm
03 Sept 2024agm
10 Jul 2024agm
06 Sept 2023agm
02 Apr 2014splitStock Split From Rs.10 to Rs.502 May 2014

Read More

Peer Comparison

No Result Found

Rekvina Labs Ltd logo

Rekvina Labs Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Lupin Ltd logo

Lupin Ltd

Read More

Rekvina Labs Ltd About

Rekvina Labs is engaged manufactures pharmaceutical products. The Company markets its products to healthcare providers, facilities, and researchers throughout India and internationally'.

Industry

Trading

Founded

1988

Headquarters

CEO

ILA RAJENDRA PATHAK

Employees

Contact

Website icon

Website

http://www.rekvinalaboratories.com

Email icon

Email

rekvina@gmail.com

Phone icon

Phone

91-265-2362966

Location icon

Location

328 Paradise Complex, Sayajigunj, Vadodara, Gujarat, 390005

Read More

Rekvina Labs Ltd Company History

YearHistory
1985
  • Rekvina was established as a small domestic company.
2014
  • Rekvina Laboratories split its face value from Rs 10/- to 5/-
2020
  • The company aims to attain a size of 100 crore INR.

Read More

Deals

Client NameOrder SideQTYAvg PriceDate
PRIYANKA JAINBuy3601223.6320 Feb 2026
ARCADIA SHARE & STOCK BROKERS PVT. LTDSell1396075.2226 Jun 2018
SURBHIT MUKESH SHAHBuy902075.2226 Jun 2018
MUKESH JAMNADAS SHAHBuy345935.2326 Jun 2018
MUKESH JAMNADAS SHAHBuy750005.2525 Jun 2018
AMIT MUKESH SHAHBuy750005.2525 Jun 2018
ARCADIA SHARE & STOCK BROKERS PVT. LTDSell1500005.2525 Jun 2018
G N CREDITS PRIVATE LIMITEDSell345605.111 Apr 2017
GIRI RAJ POKHRALSell648755.111 Apr 2017
SOBHANANDSell565005.111 Apr 2017

Read More

Rekvina Labs Ltd News

Rekvina Labs EGM Set for April 10 for Capital Increase

Rekvina Laboratories schedules extraordinary general meeting on April 10, 2026 to approve authorized share capital increase from ₹3.50 crore to ₹6 crore and other corporate actions.

18 Mar 2026

companies

Vivro Announces Open Offer for Rekvina Labs Shares

Vivro Financial Services manages open offer by three acquirers to purchase up to 28,90,100 equity shares of Rekvina Laboratories at ₹10 per share, totaling ₹2,89,01,000 consideration.

16 Mar 2026

companies

Rekvina Labs Approves ₹4.62 Cr Radiant Acquisition

Rekvina Laboratories board approves acquisition of 100% stake in Radiant Parenterals for ₹4,62,77,500/- through share swap, increases authorized capital to ₹6 crores.

16 Mar 2026

companies

Read More

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Stocks:

AllABCDEFGHIJKLMNOPQRSTUVWXYZ

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Others:

NSEBSECDSLNSDLSEBIMCXMSEINCDEXNSE IFSCINDIA INXAccount Closure FormDP Investor CharterBroker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800